J&J loses venue fight for talc lawsuits in Missouri
Reuters
Published Jan 27, 2017 03:47PM ET
J&J loses venue fight for talc lawsuits in Missouri
By Erica Teichert
(Reuters) - The Missouri Supreme Court has denied Johnson & Johnson's bid to move out of a St. Louis state court thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.
The state high court on Tuesday this week rejected an appeal by J&J (N:JNJ) seeking to transfer most of the 2,500 lawsuits pending in state court in St. Louis to courts across the country where the plaintiffs are located.
The plaintiffs are women and their families who claim studies show J&J's Baby Powder and Shower to Shower products increase the risk of ovarian cancer when used in the vaginal area. J&J has said more comprehensive studies show no such link.
St. Louis has become the main destination for talc lawsuits nationally, and J&J has been hit with three straight jury verdicts there, totaling $195 million. The company had hoped to reverse that trend by changing the venues for the cases to potentially friendlier jurisdictions.
In September, a state court judge in New Jersey, where J&J is based, dismissed two talc lawsuits against the company.
J&J spokeswoman Carol Goodrich declined to comment on the Missouri Supreme Court's decision.
The company had argued in court filings that plaintiffs' attorneys tainted the St. Louis jury pool by spending nearly $10 million on television commercials in the last year, with a disproportionate amount running in St. Louis. Plaintiffs' lawyers have denied the allegation.
Ted Meadows, one of the plaintiffs' lawyers, said in a statement on Wednesday that the Missouri Supreme Court affirmed plaintiffs' right to file their claims in a single location.
The next trial is slated to start on Feb. 6 in St. Louis. In that case, Nora Daniels of Columbia, Tennessee, alleges she used J&J Baby Powder for 36 years and was diagnosed with ovarian cancer in 2013.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.